KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Return on Equity (2016 - 2025)

Historic Return on Equity for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to 0.24%.

  • Resmed's Return on Equity changed 0.0% to 0.24% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.24%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.26% for FY2025, which is 300.0% up from last year.
  • According to the latest figures from Q4 2025, Resmed's Return on Equity is 0.24%, which was down 0.0% from 0.24% recorded in Q3 2025.
  • Resmed's 5-year Return on Equity high stood at 0.24% for Q2 2025, and its period low was 0.16% during Q1 2021.
  • Moreover, its 5-year median value for Return on Equity was 0.22% (2023), whereas its average is 0.22%.
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by -900bps in 2021, then soared by 800bps in 2022.
  • Over the past 5 years, Resmed's Return on Equity (Quarter) stood at 0.17% in 2021, then skyrocketed by 33bps to 0.23% in 2022, then dropped by -10bps to 0.2% in 2023, then rose by 17bps to 0.24% in 2024, then decreased by 0bps to 0.24% in 2025.
  • Its last three reported values are 0.24% in Q4 2025, 0.24% for Q3 2025, and 0.24% during Q2 2025.